輸入代號或公司名稱後按 Enter
4129

聯合

+0.20 (+0.24%)最後更新 2026-09-15
台灣 · 上櫃 · 生技醫療業
82.60163成交張數14.44本益比2.04股價淨值比5.45%殖利率2026-09-15資料日期

綜合損益表公開資訊觀測站申報原值 · 年度(第 4 季累計) · 每一格 = 該科目 ÷ 營業收入 · 未來期間為分析師共識預估(2026-09-09)

營業收入20255,655年增 +21.5%
毛利率202577.8%最新一期
營業利益率202513.1%最新一期
每股盈餘20255.83年增 +23.0%
會計項目走勢20162017201820192020202120222023202420252026 預估 4 家2027 預估 1 家
營業收入合計100.0%100.0%100.0%100.0%100.0%100.0%100.0%100.0%100.0%100.0%100.0%100.0%
營業成本合計31.5%27.5%30.7%29.3%29.9%28.4%25.4%22.7%22.2%22.2%
營業毛利(毛損)68.5%72.5%69.3%70.7%70.1%71.6%74.6%77.3%77.8%77.8%78.5%78.2%
已實現銷貨(損)益2.3%-0.4%-0.6%0.6%0.2%0.1%0.0%0.4%0.0%0.1%
營業毛利(毛損)淨額70.8%72.1%68.7%71.3%70.3%71.7%74.3%77.6%77.9%77.9%
推銷費用37.0%42.7%46.4%50.9%50.0%51.2%50.1%51.3%53.2%53.8%
管理費用10.6%11.2%10.2%9.2%9.6%8.6%8.2%7.6%6.5%6.3%
研究發展費用11.7%10.1%8.6%7.7%6.6%5.6%5.3%4.7%4.7%4.6%
預期信用減損損失(利益)-0.1%0.0%0.2%0.0%-0.0%0.2%0.3%0.1%
營業費用合計59.3%63.9%65.0%67.9%66.5%65.4%63.6%63.8%64.8%64.8%
營業利益(損失)11.5%8.2%3.6%3.3%3.8%6.3%10.8%13.8%13.1%13.1%12.6%12.5%
利息收入0.2%0.1%0.1%0.2%0.2%0.3%
其他收入3.0%2.1%2.0%2.7%2.5%1.0%1.1%1.2%0.9%1.0%
其他利益及損失淨額-1.7%-1.5%0.4%-0.2%0.1%-1.9%1.3%0.9%0.6%1.0%
財務成本淨額0.4%0.7%1.1%1.4%1.3%0.7%0.8%1.1%0.9%0.8%
採用權益法認列之關聯企業及合資損益之份額淨額-1.0%0.3%-0.2%-0.8%-0.6%-1.9%-3.0%-1.9%-1.5%-1.2%
營業外收入及支出合計-0.1%0.2%1.0%0.4%0.8%-3.4%-1.2%-0.9%-0.7%0.3%
稅前淨利(淨損)11.5%8.4%4.6%3.7%4.7%2.9%9.6%13.0%12.4%13.4%
所得稅費用(利益)合計1.3%2.8%0.2%0.8%0.3%0.8%2.5%3.1%2.5%3.3%
繼續營業單位本期淨利(淨損)10.2%5.6%4.4%2.9%4.3%2.1%7.1%9.9%9.9%10.1%
本期淨利(淨損)10.2%5.6%4.4%2.9%4.3%2.1%7.1%9.9%9.9%10.1%
確定福利計畫之再衡量數-0.1%-0.0%-0.1%0.0%0.0%-0.1%0.4%-0.0%0.1%-0.0%
透過其他綜合損益按公允價值衡量之權益工具投資未實現評價損益-0.1%-0.0%0.0%-0.0%-0.0%0.1%0.0%0.1%
不重分類至損益之項目:0.0%0.0%-0.1%0.4%0.0%0.2%0.0%
國外營運機構財務報表換算之兌換差額-3.5%-0.6%0.0%-0.7%0.1%-1.8%1.0%0.1%0.5%0.2%
採用權益法認列之關聯企業及合資之其他綜合損益之份額-可能重分類至損益之項目-0.9%0.4%-0.2%0.2%-0.2%0.3%0.0%
後續可能重分類至損益之項目:-1.6%0.6%-2.0%1.2%-0.1%0.8%0.2%
其他綜合損益(淨額)-3.5%-0.9%-0.6%-1.6%0.6%-2.1%1.6%-0.1%0.9%0.3%
本期綜合損益總額6.6%4.8%3.8%1.3%4.9%-0.0%8.7%9.8%10.8%10.4%
母公司業主(淨利∕損)10.6%6.6%5.5%3.6%4.3%2.0%7.0%9.8%9.8%9.9%9.4%9.3%
非控制權益(淨利∕損)-0.4%-1.0%-1.1%-0.7%-0.0%0.0%0.1%0.1%0.1%0.2%
母公司業主(綜合損益)7.4%5.8%4.9%2.0%4.9%0.0%8.6%9.7%10.7%10.2%
非控制權益(綜合損益)-0.8%-1.0%-1.1%-0.6%-0.0%-0.1%0.1%0.1%0.1%0.2%
基本每股盈餘0.1%0.1%0.1%0.0%0.1%0.0%0.1%0.1%0.1%0.1%0.1%0.1%
稀釋每股盈餘0.1%0.1%0.1%0.0%0.0%0.0%0.1%0.1%0.1%0.1%
未實現銷貨(損)益0.2%0.0%
採用權益法認列之關聯企業及合資之其他綜合損益之份額-不重分類至損益之項目-0.0%0.0%
與可能重分類之項目相關之所得稅-0.3%0.0%0.0%0.0%
採用權益法認列關聯企業及合資之其他綜合損益之份額-可能重分類至損益之項目-0.3%-0.4%
與待出售非流動資產直接相關之權益-0.3%

金額為公司申報原值除以一千(百萬元,四捨五入),每股金額為元。年度為第 4 季的年初至今累計數。最右邊的預估欄是分析師共識預估(2026-09-09),營收、營業利益、母公司淨利、每股盈餘直接取共識平均,毛利由共識營收乘上共識毛利率推算,不是公司財測。走勢條是歷史各期的相對大小,藍為正、綠為負。年增以去年同期為基期,基期非正數或變動超過十倍時不列。 權益變動表在申報資料分頁。